Senior insider sale
Chief Financial Officer at ACADIA PHARMACEUTICALS INC — senior position signals high conviction
$158.8K
5.85K shares
What this filing means
SCHNEYER MARK C. plans to sell 5.85K shares of ACADIA PHARMACEUTICALS INC valued at approximately $158.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/5/2026ACC: 0001967940-26-000042
Officer· Chief Financial Officer
Since Dec 2021
5.85K
Shares to sell
$158.8K
Approx. market value
5.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/5/2026
5.85KTotal acquired5.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/5/2026 | Stock Option Exercise Cash | 5.85K | — |
| Total | 5.85K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
5.85K
Market value
$158.8K
8/5/2026
Total
Units
5.85K
Value
$158.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/5/2026 | 5.85K | $158.8K | Nasdaq | Planned |
| Total | 5.85K | $158.8K | ||